REBINAZIL Trademark

Trademark Overview

On Thursday, January 16, 2020, a trademark application was filed for REBINAZIL with the United States Patent and Trademark Office. The USPTO has given the REBINAZIL trademark a serial number of 88762329. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Thursday, July 1, 2021. The REBINAZIL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations acting on the central nervous system; Therapeutic pharmaceutical for the treatment of brain disease in humans
rebinazil

General Information

Serial Number88762329
Word MarkREBINAZIL
Filing DateThursday, January 16, 2020
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateThursday, July 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations acting on the central nervous system; Therapeutic pharmaceutical for the treatment of brain disease in humans

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, July 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressSaint Johns, FL 32259
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressSaint Johns, FL 32259

Trademark Events

Event DateEvent Description
Thursday, July 1, 2021ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Thursday, July 1, 2021ABANDONMENT - AFTER INTER PARTES DECISION
Thursday, July 1, 2021OPPOSITION TERMINATED NO. 999999
Thursday, July 1, 2021OPPOSITION SUSTAINED NO. 999999
Wednesday, March 31, 2021OPPOSITION INSTITUTED NO. 999999
Wednesday, January 6, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 18, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 4, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, October 30, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, October 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 6, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, October 5, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, October 5, 2020FINAL REFUSAL E-MAILED
Monday, October 5, 2020FINAL REFUSAL WRITTEN
Saturday, September 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 11, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 10, 2020NON-FINAL ACTION E-MAILED
Friday, April 10, 2020NON-FINAL ACTION WRITTEN
Friday, April 10, 2020REMOVED FROM TEAS PLUS
Friday, April 3, 2020ASSIGNED TO EXAMINER
Thursday, January 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 20, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

rebinazil pharmaceutical treatment brain disease humans therapeutic system preparations acting central